Elevance Health Dividends and Buybacks

Dividend criteria checks 5/6

Elevance Health is a dividend paying company with a current yield of 1.66% that is well covered by earnings. Next payment date is on 25th June, 2025 with an ex-dividend date of 10th June, 2025.

Key information

1.7%

Dividend yield

3.5%

Buyback Yield

Total Shareholder Yield5.2%
Future Dividend Yield1.9%
Dividend Growth11.9%
Next dividend pay date25 Jun 25
Ex dividend date10 Jun 25
Dividend per sharen/a
Payout ratio26%

Recent dividend and buyback updates

Elevance Health (NYSE:ELV) Is Increasing Its Dividend To $1.71

Feb 18
Elevance Health (NYSE:ELV) Is Increasing Its Dividend To $1.71

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71

Jan 26
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71

Recent updates

Elevance Health (NYSE:ELV) Has A Pretty Healthy Balance Sheet

May 11
Elevance Health (NYSE:ELV) Has A Pretty Healthy Balance Sheet

Elevance Health: Carelon Growth Not Fully Appreciated

Apr 23

Elevance Health (NYSE:ELV) Has More To Do To Multiply In Value Going Forward

Apr 15
Elevance Health (NYSE:ELV) Has More To Do To Multiply In Value Going Forward

Elevance Health: A Hidden Gem Amongst Healthcare Turbulence

Apr 15

Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio

Mar 13

Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now

Feb 27

Elevance Health (NYSE:ELV) Is Increasing Its Dividend To $1.71

Feb 18
Elevance Health (NYSE:ELV) Is Increasing Its Dividend To $1.71

It's A Story Of Risk Vs Reward With Elevance Health, Inc. (NYSE:ELV)

Feb 10
It's A Story Of Risk Vs Reward With Elevance Health, Inc. (NYSE:ELV)

Elevance Health: Trading At Depressed Levels, So We Added Modestly

Jan 30

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71

Jan 26
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.71

Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress

Jan 23

Is There Now An Opportunity In Elevance Health, Inc. (NYSE:ELV)?

Jan 15
Is There Now An Opportunity In Elevance Health, Inc. (NYSE:ELV)?
author-image

ELV Market Outlook

This industry includes companies primarily engaged in providing health insurance products, managed care plans, and related healthcare services. These companies play a critical role in financing and ma

Elevance Health Is An Undervalued Healthcare Juggernaut

Dec 26

Returns Are Gaining Momentum At Elevance Health (NYSE:ELV)

Dec 15
Returns Are Gaining Momentum At Elevance Health (NYSE:ELV)

Elevance Health: A Quality Underpriced Stock Returning To Health

Dec 11

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Nov 30
Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29
We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds

Oct 17

Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%

Oct 10

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Oct 08
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Sep 11
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth

Sep 06

There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Aug 29
There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Aug 02
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Elevance Health: Healthcare Services Segment Is Gaining Traction

Jul 31

Elevance Health: Buy A Dividend Growth Machine

Jul 18

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Jun 28

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Jun 11
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

May 27
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

Apr 23

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Apr 11

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07
author-image

Strategic Expansions and Investments Drive Growth and Diversify Revenue Streams

Expansion in high-growth areas like infusible therapies through acquisitions aims to diversify income by servicing a broader client base.

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Upcoming Dividend Payment

TodayMay 21 2025Ex Dividend DateJun 10 2025Dividend Pay DateJun 25 202515 days from Ex DividendBuy in the next 20 days to receive the upcoming dividend

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: ELV's dividends per share have been stable in the past 10 years.

Growing Dividend: ELV's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Elevance Health Dividend Yield vs Market
How does ELV dividend yield compare to the market?
SegmentDividend Yield
Company (ELV)1.7%
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Healthcare)2.2%
Analyst forecast (ELV) (up to 3 years)1.9%

Notable Dividend: ELV's dividend (1.66%) is higher than the bottom 25% of dividend payers in the US market (1.54%).

High Dividend: ELV's dividend (1.66%) is low compared to the top 25% of dividend payers in the US market (4.67%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (25.7%), ELV's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (42.1%), ELV's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/20 22:05
End of Day Share Price 2025/05/20 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elevance Health, Inc. is covered by 48 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Hua HaBaird
Ishan MajumdarBaptista Research